eGFR and ACR categories and risk of adverse outcomes | ACR categories (mg/g Cr), description and range | |||||
---|---|---|---|---|---|---|
<30 | 30–300 | >300 | ||||
Normal to mildly increased | Moderately increased | Severely increased | ||||
Normoalbuminuria | Microalbuminuria | Macroalbuminuria | ||||
A1 | A2 | A3 | Total | |||
GFR categories (ml/min/1.73 m2) | ≥90 Normal and high | G1 | 612 (48.4%) [137,188] | 37 (2.8%) [7919] | 5 (0.3%) [940] | 654 (51.5%) [146,047] |
60–89 Mild reduction | G2 | 658 (45.3%) [128,547] | 23 (1.6%) [4647] | 2 (0.1%) [356] | 683 (47.1%) [133,550] | |
30–59.9 Moderate impairment | G3 | 17 (1.1%) [3125] | 0 | 2 (0.1%) [348] | 19 (1.2%) [3473] | |
15–29.9 Severe impairment | G4 | 1 (0.1%) [194] | 0 | 1 (0.1%) [222] | 2 (0.1%) [416] | |
<15 Kidney failure | G5 | 0 | 0 | 1 (0.1%) [165] | 1 (0.1%) [165] | |
Total | 1288 (94.9%) [269,054] | 60 (4.4%) [12,566] | 11 (0.7%) [2032] | 1359 (100%) [283,652] |